While most biotechs chase lab-grown solutions, Kerecis found gold in the ocean. By grafting intact fish skin onto human wounds, they've built a $226M revenue machine with 643 employees. This isn't just biotech—it's biomimicry at its most primal.

"In a world of complex biologics, Kerecis proves the most elegant solution is often the one that's already optimized by 400 million years of evolution."

The keyword strategy reveals a sophisticated understanding of their market. They rank for high-intent terms like 'kerecis omega3 marigen shield' (240 searches) while also capturing broader wound care queries. The fact that 'fish skin burns healed' generates 330 monthly searches shows they've successfully repositioned a natural remedy as a clinical standard.

• Intact fish skin grafts for chronic wounds—no processing, just nature's design
• Omega-3 fatty acids naturally embedded in the skin reduce inflammation
• FDA-cleared and CE-marked, avoiding the regulatory nightmare of novel biologics
• Scalable production: fish skin is abundant, consistent, and ethically sourced